Literature DB >> 19299334

Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates.

Hilario J Ramos1, Ann M Davis, Alexander G Cole, John D Schatzle, James Forman, J David Farrar.   

Abstract

Multiple innate signals regulate the genesis of effector and memory CD8+ T cells. In this study, we demonstrate that the innate cytokines interleukin (IL)-12 and interferon (IFN)-alpha/beta regulate distinct aspects of effector and memory human CD8+ T-cell differentiation. IL-12 exclusively promoted the development of IFN-gamma- and tumor necrosis factor (TNF)-alpha-secreting T effector memory (T(EM)) cells, whereas IFN-alpha drove the development of T central memory (T(CM)) cells. The development of T(EM) and T(CM) was linked to cell division. In rapidly dividing cells, IL-12 programmed T(EM) through induction of the IL-12 receptor beta2. In contrast, IFN-alpha regulated T(CM) development by slowing the progression of cell division in a subpopulation of cells that selectively expressed elevated IFN-alpha/beta receptor-2. The strength of signal delivered through T-cell receptor (TCR) engagement regulated the responsiveness of cells to IL-12 and IFN-alpha. In the presence of both IL-12 and IFN-alpha, these cytokine signals were amplified as the strength of the TCR signal was increased, promoting the simultaneous development of both T(CM) and T(EM). Together, our results support a novel model in which IL-12 and IFN-alpha act in a nonredundant manner to regulate the colinear generation of both effector and memory cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299334      PMCID: PMC2689051          DOI: 10.1182/blood-2008-11-188458

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo.

Authors:  C S Schmidt; M F Mescher
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

2.  Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells.

Authors:  J M Curtsinger; C S Schmidt; A Mondino; D C Lins; R M Kedl; M K Jenkins; M F Mescher
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

3.  High expression of active CDK6 in the cytoplasm of CD8 memory cells favors rapid division.

Authors:  Henrique Veiga-Fernandes; Benedita Rocha
Journal:  Nat Immunol       Date:  2003-11-30       Impact factor: 25.606

4.  Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines.

Authors:  Jens Geginat; Antonio Lanzavecchia; Federica Sallusto
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

5.  IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells.

Authors:  Jun Chang; Jae-Ho Cho; Seung-Woo Lee; So-Young Choi; Sang-Jun Ha; Young-Chul Sung
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

6.  Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.

Authors:  T Kataoka; N Shinohara; H Takayama; K Takaku; S Kondo; S Yonehara; K Nagai
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

7.  Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity.

Authors:  T Kataoka; K Takaku; J Magae; N Shinohara; H Takayama; S Kondo; K Nagai
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

8.  Memory CD4 T cells emerge from effector T-cell progenitors.

Authors:  Laurie E Harrington; Karen M Janowski; James R Oliver; Allan J Zajac; Casey T Weaver
Journal:  Nature       Date:  2008-03-05       Impact factor: 49.962

9.  Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection.

Authors:  L P Cousens; R Peterson; S Hsu; A Dorner; J D Altman; R Ahmed; C A Biron
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

10.  Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells.

Authors:  L L Carter; K M Murphy
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

View more
  37 in total

1.  Unique Th1/Th2 phenotypes induced during priming and memory phases by use of interleukin-12 (IL-12) or IL-28B vaccine adjuvants in rhesus macaques.

Authors:  Matthew P Morrow; Jian Yan; Panyupa Pankhong; Bernadette Ferraro; Mark G Lewis; Amir S Khan; Niranjan Y Sardesai; David B Weiner
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

Review 2.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

3.  Mucosal polyinosinic-polycytidylic acid improves protection elicited by replicating influenza vaccines via enhanced dendritic cell function and T cell immunity.

Authors:  José V Pérez-Girón; Alan Belicha-Villanueva; Ebrahim Hassan; Sergio Gómez-Medina; Jazmina L G Cruz; Anja Lüdtke; Paula Ruibal; Randy A Albrecht; Adolfo García-Sastre; César Muñoz-Fontela
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

Review 4.  Regulation of effector and memory T-cell functions by type I interferon.

Authors:  Jonathan P Huber; J David Farrar
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

5.  IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo.

Authors:  Fatema Z Chowdhury; Hilario J Ramos; Laurie S Davis; James Forman; J David Farrar
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

6.  Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.

Authors:  M A Rochat; E Schlaepfer; R F Speck
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

7.  Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.

Authors:  Maria Lisa Knudsen; Karl Ljungberg; Maria Kakoulidou; Linda Kostic; David Hallengärd; Juan García-Arriaza; Andres Merits; Mariano Esteban; Peter Liljeström
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 8.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

9.  IFN-α suppresses GATA3 transcription from a distal exon and promotes H3K27 trimethylation of the CNS-1 enhancer in human Th2 cells.

Authors:  Jonathan P Huber; Sarah R Gonzales-van Horn; Kole T Roybal; Michelle A Gill; J David Farrar
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

10.  Yeast virus-derived stimulator of the innate immune system augments the efficacy of virus vector-based immunotherapy.

Authors:  Marie-Christine Claudepierre; Julie Hortelano; Emmanuelle Schaedler; Patricia Kleinpeter; Michel Geist; Christelle Remy-Ziller; Renée Brandely; Caroline Tosch; Laurence Laruelle; Anass Jawhari; Thierry Menguy; Jean-Baptiste Marchand; Pascale Romby; Patrick Schultz; Gunther Hartmann; Ronald Rooke; Jean-Yves Bonnefoy; Xavier Preville; Karola Rittner
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.